This Solicitation opportunity from Department Of Defense was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
CLINDAMYCIN PHOSPHA
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Clindamycin Phosphate Topical Gel, 1%, equivalent to 10 mg of clindamycin per mL in a 30 gram unit, is being procured under solicitation SPE2DP-26-T-3406 for delivery to the Department of Defense Medical Supply Chain Pharmaceutical Federal Supply Activity. The contract specifies a quantity of two units of issue, where each unit equals three individual packages, totaling six units. Delivery is required within ten days of award, FOB destination, with a mandatory delivery date of May 18, 2026, and no variance in quantity is permitted. The item is classified as a TYPE I (CODE K) medical product with a strict 18-month non-extendable shelf life, and all packaging must adhere to the DLA Master List of Technical and Quality Requirements, which supersedes other standards. Medical Marking Standard No. 1 replaces MIL-STD-129 for labeling and marking, and palletization must follow RP001 packaging guidelines. Packaging must be commercial-grade: non-hazardous materials require ASTM D3951 compliance, while hazardous materials must meet TQ requirement IP025 per FED-STD-313. Each unit must be sealed in protective containers, and all shipments must ensure safe transport at the lowest carrier rate. The product is regulated by the FDA, and buyers must submit an electronic referral to confirm bidder and manufacturer details. Hazardous material data, including Safety Data Sheets and labeling compliant with 29 CFR 1910.1200, must be provided prior to award, with updates required during performance. Invoicing must be completed through the Wide Area WorkFlow system, and the contracting officer contact is Imerah Burnett. Offerors must hold a valid UEI and CAGE code, and socioeconomic certifications for small business categories—including EDWOSB, HUBZone, SDVOSB, and WOSB—are required where applicable. The solicitation incorporates clauses mandating equal opportunity, combating trafficking, employment eligibility verification, safeguarding contractor information systems, and NIST SP 800-171 compliance. Award will be made based on compliance with all technical and regulatory requirements, though pricing details are not provided in the solicitation.
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
CLINDAMYCIN PHOSPHATE TOPICAL GEL,1%,EQUIVALENT
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
TO 10 MG OF CLINDAMYCIN PER ML, 30 GRAM
UPJOHN NDC0009-3331-02
FOUGERA NDC 00168-0202-30
UNIT OF ISSUE-TU
MGAC BCHAMBERLIN 04124
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 TU = 3 EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-3406
SECTION B
RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
PADAGIS US LLC 9MGE4 P/N NDC45802-0900-94
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016781172 0001 TU 2.000
NSN/MATERIAL:6505012850797
DELIVERY (IN DAYS):0010
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF3
0008 MD CO MEDICAL LOGISTI
8TH MLC TASL MEDICAL BLDG 8343
SMITH BKS AULENBACHERSTR
BAUMHOLDER 55774
DE
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
W50YF3
SPE2DP-26-T-3406
SECTION B
PR: 7016781172 PRLI: 0001 CONT’D
0008 MD CO MEDICAL LOGISTI
8TH MLC TASL MEDICAL BLDG 8343
SMITH BKS AULENBACHERSTR
BAUMHOLDER 55774
DE
MARKFOR
W50YF3
0008 MD CO MEDICAL LOGISTI
8TH MLC TASL MEDICAL BLDG 8343
SMITH BKS AULENBACHERSTR
BAUMHOLDER 55774
DE
M/F: (TCN) W50YF361330007
RDD: 147
PROJ: 9GU TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A01 DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:05/18/2026
SPE2DP-26-T-3406 NSN/Part Number: 6505-01-285-0797 Quantity: 2 TU Purchase Request: 7016781172QTY: 2 Delivery: 10 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS